Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Venture Financing 13
Aptiv Solutions Raises US$5.7 Million In Venture Financing 13
Merger 14
Inclinix Merges With PMG Research 14
Licensing Agreements 15
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
Debt Offering 16
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
Acquisition 17
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc – Key Competitors 24
ICON Plc – Key Employees 25
ICON Plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Mar 29, 2018: ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution 29
Mar 14, 2018: ICON opens a new office in Boston 30
Financial Announcements 31
Oct 24, 2018: ICON Reports Third Quarter 2018 Results 31
Oct 24, 2018: ICON reports third quarter 2018 results 33
Jul 25, 2018: ICON Reports Second Quarter 2018 Results 35
May 02, 2018: ICON Reports First Quarter 2018 Results 37
Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 38
Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 40
Oct 26, 2017: ICON Reports Third Quarter 2017 Results 41
Jul 27, 2017: ICON Reports Second Quarter 2017 Results 42
Apr 27, 2017: ICON Reports First Quarter 2017 Results 43
Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 44
Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 45
Corporate Communications 46
Jul 27, 2018: ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe 46
Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 47
Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 48
Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 49
Government and Public Interest 50
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 50
Product News 52
Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 52
Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 53
Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 54
Other Significant Developments 55
Oct 01, 2018: ICON announces release of ADDPLAN Neo 55
Jun 22, 2018: ICON and DIA driving Insights to Action with DIA Live 2018 56
Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 57
Nov 21, 2017: FIRECREST Pre-Screen improves sponsor visibility of patient access 58
Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 59
Oct 27, 2017: ICON and ICHOM unveil the world’s first global patient outcomes benchmarking platform 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Aptiv Solutions Raises US$5.7 Million In Venture Financing 13
Inclinix Merges With PMG Research 14
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc, Key Competitors 24
ICON Plc, Key Employees 25
ICON Plc, Subsidiaries 26
List of Figures
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10